Skip to main content

Aplicación de fluidos supercríticos para la obtención de prebióticos procedentes de microalgas

JDC2022-048768-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprogram Subprograma Estatal de Formación
Call Juan de la Cierva
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Digestibility and Microbiota Modulation by Nuts and Sunflower Seeds in Cystic Fibrosis: An In Vitro Approach

  • Viteri-Echeverría, Jazmín Dayumara
  • Heredia Gutiérrez, Ana Belén|||0000-0001-6629-9779
  • Andrés Grau, Ana María|||0000-0002-6132-3167
  • Calvo-Lerma, Joaquim
  • Asensio-Grau, Andrea
[EN] Purpose: This study evaluated the lipid and protein digestibility and the prebiotic potential of almonds, hazelnuts, peanuts, and sunflower seeds through static in vitro gastrointestinal digestion and colonic fermentation, comparing healthy and cystic fibrosis (CF) conditions. Methods: The CF model included reduced pH, low bile salt concentration, and pancreatic enzyme replacement therapy. Digestibility was assessed via matrix degradation, proteolysis, and lipolysis, while microbiota composition and metabolic activity were analysed using faecal inoculum from paediatric CF donors. Results: Sunflower seeds and peanuts showed the highest lipolysis under CF conditions (46%), with sunflower seeds also achieving the highest proteolysis (457 mg tyrosine/g food). Beta-diversity analyses revealed significant differences in microbiota composition after simulated colonic fermentation between the four food samples, with sunflower seeds uniquely reducing Acidaminococcus and increasing the production of linear-chain short-chain fatty acids and lactate. In contrast, almonds exhibited notably low proteolysis, potentially due to antinutritional factors. Conclusion: These findings highlight the differential digestibility and microbiota modulation of nuts and seeds under CF-specific conditions, with sunflower seeds emerging as a promising dietary component for children with CF., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by Universitat Politècnica de València, (First Project Grant, ref. PAID-06- 22). We acknowledged to Universitat Politècnica de València for the pre-doctoral grant (PAID-01-22) awarded to Jazmín Viteri-Echeverría. We also thank the Juan de la Cierva formation post-doctoral contract awarded to Andrea Asensio-Grau by the Spanish Ministry of Science and Innovation (JDC2022-048768-I).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Assessment of the Isolated and Combined Impact of beta-Glucan and Lacticaseibacillus rhamnosus on Cystic Fibrosis Gut Microbiota Using a SHIME® System

  • Viteri-Echeverría, Jazmín Dayumara|||0000-0002-7692-9161
  • García Hernández, Jorge|||0000-0003-1258-6128
  • Heredia Gutiérrez, Ana Belén|||0000-0001-6629-9779
  • Andrés Grau, Ana María|||0000-0002-6132-3167
  • Calvo-Lerma, Joaquim
  • Asensio-Grau, Andrea
[EN] Background: Cystic fibrosis (CF) is a genetic disorder that disrupts gut microbiota com position, promoting dysbiosis associated with chronic inflammation, impaired nutrient absorption, and poor clinical outcomes. While modulation of the intestinal microbiota through prebiotics, probiotics, and synbiotics has been proposed as a therapeutic strategy, clinical evidence remains limited, especially in children. Objective: This study aimed to evaluate the impact of three supplementation strategies (a prebiotic (ß-glucan), a probiotic (Lacticaseibacillus rhamnosus GG), and their synbiotic combination) on the gut microbiota and metabolic activity of a CF child faecal donor using a dynamic in vitro colonic fermenta tion model (SHIME®). Methods: Microbial composition (16S rRNA gene sequencing), and metabolic activity (quantification of short-chain fatty acids (SCFAs), ammonia, and lactate) were analysed. Results: Results showed that the prebiotic increased alpha diversity; while both the prebiotic and probiotic treatments significantly reduced Bacillota and increased Bacteroidota, modulating the Bacillota/Bacteroidota ratio. The synbiotic treatment showed the most beneficial overall profile, including enhanced production of SCFAs, particularly butyrate and propionate, and increased abundance of Faecalibacterium and Agathobacter, which are two bacterial genera generally associated with gut health. Notably, the synbiotic also reduced the relative abundance of potentially pathogenic genera such as Veillonella, Megasphaera, and Stenotrophomonas, but paralleled with an increase in Clostridium ss 1. Although the probiotic alone showed some positive effects, it was less effective overall compared to the prebiotic and synbiotic approaches. Conclusions: These findings support the potential of synbiotic supplementation as a promising strategy to modulate gut dys biosis in CF, though in vivo studies are needed to confirm the translational relevance of these results., This work was funded by the Universitat Politècnica de València within the framework of the grant awarded to Andrea Asensio-Grau (Grants for First Research Projects 2022, ref. PAID-06-22). The authors also thank the Universitat Politècnica de València for the support granted to Jazmín Viteri-Echeverría [Predoctoral Contract Grants-SUBPR 1, ref. PAID-01-22]. Andrea Asensio-Grau acknowledges the Juan de la Cierva postdoctoral research grant awarded by the Spanish Ministry of Science and Innovation (JDC2022-048768-I).